A Randomized Trial on the Efficacy of Topical Estrogen vs. Vaginal Laser  Therapy for Postmenopausal Vaginal Atrophy and Urinary Incontinence

Asma IhsanSidra ShafiqNishat AkramAqsa Tariq, Wajiha MehwishSaima Abid, Rahul Deb, Farah Naz Tahir

A Randomized Trial on the Efficacy of Topical Estrogen vs. Vaginal Laser Therapy for Postmenopausal Vaginal Atrophy and Urinary Incontinence

Authors

Asma IhsanSidra ShafiqNishat AkramAqsa Tariq, Wajiha MehwishSaima Abid, Rahul Deb, Farah Naz Tahir

Keywords:

vaginal atrophy; estrogen cream; vaginal laser; urinary incontinence.

Abstract

A randomized controlled trial evaluated the efficacy of topical estrogen (TE) versus fractional CO₂
vaginal laser therapy (VLT) in treating postmenopausal vaginal atrophy (PVA) and urinary
incontinence (UI). One hundred twenty postmenopausal women

References

Castelo-Branco C, et al. Postmenopausal vaginal atrophy: physiology, pathogenesis, and clinical presentations. Menopause Rev. 2022;21(1):22–28.

Santen RJ, et al. Low-dose topical estradiol for vulvovaginal atrophy without systemic effects. Climacteric. 2023;26(2):234–240.

Downloads

Published

2025-06-25

How to Cite

Asma IhsanSidra ShafiqNishat AkramAqsa Tariq, Wajiha MehwishSaima Abid, Rahul Deb, Farah Naz Tahir. (2025). A Randomized Trial on the Efficacy of Topical Estrogen vs. Vaginal Laser Therapy for Postmenopausal Vaginal Atrophy and Urinary Incontinence. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 83–87. Retrieved from https://ijprt.org/index.php/pub/article/view/648